The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-allyl-N-(3-((2-(3-bromophenylamino)-5-(trifluoromethyl)pyrimidin-4-ylamino)methyl)pyridin-2-yl)methanesulfonamide ID: ALA3892377
PubChem CID: 134136179
Max Phase: Preclinical
Molecular Formula: C21H20BrF3N6O2S
Molecular Weight: 557.40
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: C=CCN(c1ncccc1CNc1nc(Nc2cccc(Br)c2)ncc1C(F)(F)F)S(C)(=O)=O
Standard InChI: InChI=1S/C21H20BrF3N6O2S/c1-3-10-31(34(2,32)33)19-14(6-5-9-26-19)12-27-18-17(21(23,24)25)13-28-20(30-18)29-16-8-4-7-15(22)11-16/h3-9,11,13H,1,10,12H2,2H3,(H2,27,28,29,30)
Standard InChI Key: AZSAXICINIVCFK-UHFFFAOYSA-N
Molfile:
RDKit 2D
34 36 0 0 0 0 0 0 0 0999 V2000
6.4506 -6.1266 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.6335 -6.1412 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
6.0547 -6.8415 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.2426 -1.6839 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.2414 -2.5034 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9495 -2.9124 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.6591 -2.5029 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6563 -1.6803 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9477 -1.2750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3597 -1.2691 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0023 -0.8949 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
6.1591 -1.5696 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
5.4928 -0.4255 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
5.3675 -2.9104 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.3834 -3.7274 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0989 -4.1222 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1101 -4.9367 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8247 -5.3314 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.5253 -4.9091 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5068 -4.0879 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7916 -3.6969 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5329 -2.9122 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.4090 -5.3568 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.5919 -5.3672 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1924 -6.0801 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3752 -6.0905 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0656 -6.7287 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5259 -3.7269 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8146 -4.1263 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8073 -4.9402 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5098 -5.3544 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2212 -4.9487 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2250 -4.1362 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0959 -5.3423 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
10 11 1 0
10 12 1 0
10 13 1 0
8 10 1 0
7 14 1 0
14 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
17 23 1 0
5 22 1 0
23 24 1 0
23 2 1 0
24 25 1 0
25 26 2 0
2 27 1 0
22 28 1 0
28 29 2 0
29 30 1 0
30 31 2 0
31 32 1 0
32 33 2 0
33 28 1 0
30 34 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 557.40Molecular Weight (Monoisotopic): 556.0504AlogP: 4.96#Rotatable Bonds: 9Polar Surface Area: 100.11Molecular Species: NEUTRALHBA: 7HBD: 2#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: 13.07CX Basic pKa: 4.18CX LogP: 4.31CX LogD: 4.31Aromatic Rings: 3Heavy Atoms: 34QED Weighted: 0.36Np Likeness Score: -1.73
References 1. Farand J, Mai N, Chandrasekhar J, Newby ZE, Van Veldhuizen J, Loyer-Drew J, Venkataramani C, Guerrero J, Kwok A, Li N, Zherebina Y, Wilbert S, Zablocki J, Phillips G, Watkins WJ, Mourey R, Notte GT.. (2016) Selectivity switch between FAK and Pyk2: Macrocyclization of FAK inhibitors improves Pyk2 potency., 26 (24): [PMID:27876318 ] [10.1016/j.bmcl.2016.10.092 ]